Current Editions
Fritz Bittenbender: guiding BIO through an America First era
BIO’s new board chair on MFN pricing, political realism, and why the industry can’t just say no anymore
Politics, Policy & Law
Emerging Company Profile
How to train your dragon: Welsh spinout Draig draws $140M for CNS programs
SV Health, others back programs from Cardiff University in nine-digit series A
Data Byte
CHMP recommends five new drugs
Four of the five are already approved in the U.S.
Politics, Policy & Law
Amarin, Merck alum Karim Mikhail emerges as possible head of FDA’s CDER
The former Amarin CEO and Merck executive is serving as an adviser to Commissioner Makary
Finance
Amid market challenges, Syncona restructures fund, seeks new evergreen vehicle
U.K. firm will steer portfolio toward returns for shareholders, while aiming to build new fund away from public markets
Caris lands largest NASDAQ IPO in two years: Finance Report
Plus: Venture rounds for Welsh start-up Draig, San Diego’s Actio
BioCentury ISSN 1097-7201